Taro Pharmaceutical Industries Ltd.

TARO · NYSE
Analyze with AI
3/31/2024
12/31/2023
9/30/2023
6/30/2023
Assets
Cash & Equivalents$362,909$382,409$269,011$124,165
Short-Term Investments$516,442$519,807$638,038$681,988
Receivables$177,463$230,372$227,318$283,428
Inventory$204,817$214,816$208,188$204,592
Other Curr. Assets$41,772$39,140$46,254$56,555
Total Curr. Assets$1,303,403$1,347,404$1,342,555$1,294,173
Property Plant & Equip (Net)$217,592$218,385$189,893$189,590
Goodwill$17,231$17,231$17,231$17,231
Intangibles$0$0$0$0
Long-Term Investments$457,991$403,544$388,370$451,174
Tax Assets$83,397$97,300$100,807$101,386
Other NC Assets$82,455$79,315$80,617$81,495
Total NC Assets$858,666$815,775$776,918$840,876
Other Assets$0$0$0$0
Total Assets$2,162,069$2,163,179$2,119,473$2,135,049
Liabilities
Payables$44,664$51,183$43,059$59,368
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$316,443$322,876$318,429$325,638
Total Curr. Liab.$361,107$374,059$361,488$385,006
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$7,956$10,027$10,429$11,511
Total NC Liab.$7,956$10,027$10,429$11,511
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$369,063$384,086$371,917$396,517
Equity
Pref Stock$0$0$0$0
Common Stock$1,793,006$1,779,093$1,747,556$1,738,532
Retained Earnings$0$0$0$0
AOCI$0$0$0$0
Other Equity$0$0$0$0
Total Equity$1,793,006$1,779,093$1,747,556$1,738,532
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,162,069$2,163,179$2,119,473$2,135,049
Net Debt-$362,909-$382,409-$269,011-$124,165